首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1673889

胚胎胚胎著床前基因檢測市場類型、最終用戶和地區

Preimplantation Genetic Diagnosis Market, By Type, By End User, By Geography

出版日期: 2025年02月12日 | 出版商:

Coherent Market Insights | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球胚胎著床前基因檢測市場規模估計為 6,160 萬美元，預計到 2032 年將達到 1.042 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.8%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	6160萬美元
效能資料	從2020年到2024年	預測期	2025年至2032年
預測期：2025-2032年複合年成長率：	7.80%	2032年價值預測	1.042億美元

數字。 2025年胚胎著床前基因檢測市場佔有率（按地區）

胚胎著床前基因診斷 (PGD) 是一種 IVF 程序，在胚胎著床前從胚胎中取出一個或幾個細胞切片檢查，並檢測是否存在基因缺陷。 PGD有助於識別IVF胚胎中的基因異常，並選擇性地移植健康胚胎。這樣可以防止遺傳疾病傳給後代，並選擇沒有遺傳疾病的胚胎。不孕症率上升、隨著母親年齡成長染色體異常風險增加、人們對預防遺傳疾病的興趣日益濃厚以及 PGD 技術的進步等因素可能會在預測期內推動全球胚胎著床前基因檢測市場的成長。

市場動態：

全球胚胎著床前基因檢測市場的成長受到不孕症上升、人們對預防遺傳疾病的興趣日益濃厚以及全球範圍內母親年齡增加（導致染色體異常的可能性更高）的推動。然而，胚胎著床前基因檢測的局限性、有關胚胎著床前基因檢測的社會和倫理問題以及嚴格的監管可能會阻礙市場成長。政府和私人組織為傳播 PGD 意識而採取的各種舉措可能會提供有利可圖的市場成長機會。市場相關人員正在轉向次世代定序等新技術，以提供全面的染色體篩檢並改善結果。

本研究的主要特點

本報告對全球胚胎著床前基因檢測市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。
它揭示了不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
全球胚胎著床前基因檢測市場的主要企業是根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行的分析。
本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球胚胎著床前基因檢測市場報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員可以透過用於分析全球胚胎著床前基因檢測市場的各種策略矩陣來促進他們的決策。

公司簡介
- PerkinElmer, Inc.
- Genea Limited
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Quest Diagnostics Incorporated
- Illumina, Inc.
- CooperSurgical, Inc.
- Beijing Genomics Institute（BGI）
- LabCorp of America Holdings（Laboratory Corporation of America）
- Natera, Inc.
- Oxford Gene Technology
- California Pacific Medical Center
- Good Start Genetics, Inc.
- Invitae Corporation
- F. Hoffmann-La Roche AG
- Progenesis

第9章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI698

Global Preimplantation Genetic Diagnosis Market is estimated to be valued at USD 61.6 Mn in 2025 and is expected to reach USD 104.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 61.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.80%	2032 Value Projection:	USD 104.2 Mn

Figure. Preimplantation Genetic Diagnosis Market Share (%), By Region 2025

Preimplantation Genetic Diagnosis Market - IMG1

Preimplantation genetic diagnosis (PGD) is an in-vitro fertilization procedure in which one or few cells are biopsied from an embryo before implantation and tested for genetic defects. PGD helps to identify genetic defects in embryos developed through IVF and assists in selective implantation of healthy embryos. It aids in preventing the transmission of hereditary disorders to offspring and allows couples to choose only embryos without genetic conditions. Factors such as rising infertility rates, increasing risk of chromosomal abnormalities with advancing maternal age, growing focus on prevention of genetic disorders, and technological advancements in PGD techniques can drive the global preimplantation genetic diagnosis market growth during the forecast period.

Market Dynamics:

Global preimplantation genetic diagnosis market growth is driven by rising infertility rates, growing focus on prevention of genetic disorders, increasing maternal age globally that leads to higher chances of chromosomal abnormalities. However, limitations of PGD, social and ethical concerns regarding PGD, and stringent regulations can hamper the market growth. Various initiatives by government and private organizations to spread awareness about PGD can offer lucrative market growth opportunities. Market players are focusing on new techniques such as next-generation sequencing to provide comprehensive chromosome screening with improved outcomes.

Key Features of the Study:

This report provides in-depth analysis of the global preimplantation genetic diagnosis market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global preimplantation genetic diagnosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include CooperSurgical, Illumina, Thermo Fisher, Agilent Technologies, PerkinElmer, Abbott Laboratories, Natera, Rubicon Genomics, Oxford Gene Technology, Yikon Genomics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global preimplantation genetic diagnosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preimplantation genetic diagnosis market

Detailed Segmentation-

By Type:
- Chromosomal Abnormalities
- Aneuploidy
- X-linked diseases
- Single gene disorders
- HLA Typing
- Gender Selection
- Others
By End User
- Diagnostic Laboratories
- Hospitals
- Clinics
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- PerkinElmer, Inc.
- Genea Limited
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Quest Diagnostics Incorporated
- Illumina, Inc.
- CooperSurgical, Inc.
- Beijing Genomics Institute (BGI)
- LabCorp of America Holdings (Laboratory Corporation of America)
- Natera, Inc.
- Oxford Gene Technology
- California Pacific Medical Center
- Good Start Genetics, Inc.
- Invitae Corporation
- F. Hoffmann-La Roche AG
- Progenesis

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Preimplantation Genetic Diagnosis Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Preimplantation Genetic Diagnosis Market, By Type, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Chromosomal Abnormalities
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Aneuploidy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
X-linked diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Single gene disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
HLA Typing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Gender Selection
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Preimplantation Genetic Diagnosis Market, By End User, 2020 - 2032, (USD Mn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Preimplantation Genetic Diagnosis Market, By Region, 2020 - 2032, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Mn)
- Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- PerkinElmer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Genea Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Agilent Technologies, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Quest Diagnostics Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Illumina, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CooperSurgical, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Beijing Genomics Institute (BGI)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- LabCorp of America Holdings (Laboratory Corporation of America)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Natera, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Oxford Gene Technology
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- California Pacific Medical Center
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Good Start Genetics, Inc.
- Invitae Corporation
- F. Hoffmann-La Roche AG
- Progenesis